secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001437749-25-022675
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences names Steven T. Weber as VP Accounting and principal accounting officer
--------------------------------------------------------------------------------

- Steven T. Weber appointed VP of Accounting and Global Corporate Controller effective July 14, 2025, succeeding as principal accounting officer.
- Weber brings 25+ years of experience; most recently SVP, Corporate Controller and PAO at IGM Biosciences.
- Received start-date option for 55,000 shares at $16.03 (July 11 close), with time and performance-based vesting.
- Performance vesting tied to market cap milestones: $1.5B, $2.25B, $3.0B, $4.0B sustained for 270 days or by set dates through 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774925022675/0001437749-25-022675-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774925022675/plse20250711_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-022675

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer